A continuous glucose monitor has never been shown to make a healthy person healthier. A 2026 review pooled 23 studies in people without diabetes. It found no clear benefit for anyone who started with normal blood sugar (Review). What the patch does well is show how your body handles your own meals. Treat it as a two-week experiment, not a health check.
What a Continuous Glucose Monitor Measures
A continuous glucose monitor, or CGM, is a coin-sized patch you wear on the back of your arm. A soft thread sits just under the skin. It does not sample blood. It samples interstitial fluid, the watery space between your cells. Glucose reaches that space a few minutes after it reaches your blood.
That lag matters. A sensor and a finger prick can disagree at the same moment, and the sensor is the one making an estimate.
The standard clinic test works differently. HbA1c gives a rough average of your blood sugar over the last two or three months. It is a slow, steady number, while a CGM is a fast, twitchy one.
In 2024, US regulators cleared the first versions you can buy without a prescription. Dexcom’s Stelo came first, in March, for adults 18 and over who do not use insulin (Source). Abbott’s Lingo and Libre Rio followed in June (Source).
Clearance is permission to sell, not a verdict on usefulness. Lingo’s paperwork says it is not meant to diagnose any disease, including diabetes (Source). Stelo tells users not to act on a reading without asking a clinician (Source).
Wearing one is not cheap. Stelo launched in August 2024 at $99 for two sensors, or $89 a month by subscription (Source). Lingo arrived that September at $49 for a single 14-day sensor (Source).
Same Meal, Different Spikes
One finding built this whole industry. In 2015, researchers in Israel put sensors on 800 adults for a week, most of them overweight. They logged 46,898 real meals, plus identical ones that everybody ate twice (Study). Plain bread produced a huge spread. The bottom tenth of people barely moved. The top tenth rose more than five times as much (Study). Some people even ranked two meals in opposite orders.
So no single high-carb verdict fits everyone. Some people sail through bread and get walloped by rice.
Other groups found the same thing. A US team gave 327 adults without diabetes an identical bagel with cream cheese. Their glucose rises ranged from 6 to 94 mg/dL (Study). Across every meal they logged, they also built a model from each person’s own data. It predicted the rises better than counting carbs or calories (Study).
The biggest repeat test is PREDICT 1. Researchers fed identical meals to 1,002 UK adults, most of them twins, and saw the same wide spread. They then confirmed it in a separate group of 100 Americans (Study).
Three findings rarely reach the marketing. First, inside PREDICT 1 the meal mattered more than the person. What was on the plate explained more of the blood sugar spread than personal factors like gut bacteria (Study). Inherited genes explained roughly 30% of the differences in the two-hour glucose response, and no app can change those (Study).
Second, the trial arm everyone quotes was tiny. Twenty-six new volunteers ate a week of their personally “good” meals, then a week of their “bad” ones (Trial). A coin flip set the order, and nobody knew which week was which. The good week did lower blood sugar after meals. But the comparison was a deliberately bad personal diet, not standard dietary advice. The researchers measured only glucose and gut bacteria, one week per arm.
Third, and most awkward: your own response to the same meal repeats less reliably than early work suggested. Researchers served 30 adults duplicate meals about a week apart, in hospital conditions, and collected 1,189 responses (Trial). Agreement between the two servings was weak to moderate on both sensor brands tested. Their conclusion was blunt: personal diet advice from a CGM needs repeated readings, not one.
The Health Evidence Is Missing
Nobody has shown that a sensor makes a healthy person healthier. The strongest pooled evidence treats a CGM as a nudge to change habits. It gathered 25 trials that decided by coin flip who got a sensor, covering 2,996 people (Meta-analysis). Sensor feedback lowered the three-month average blood sugar test by about a third of a percentage point. It also raised time spent in the target range, though that result rests on only 10 trials. Weight and body size showed no clear change (Meta-analysis).
Who was in those trials matters. About two thirds had type 2 diabetes (Review). Only 3 of the 25 trials studied people without diabetes, all of them living with overweight or obesity. The three held about 130 people, roughly 4 in every 100 of the pool (Review). Eleven of the 25 trials reported money ties to sensor makers. The authors want more research in people without diabetes before anyone claims the benefit carries over.
A newer review looked only at people without diabetes: 23 studies, 1,074 people, 11 countries (Review). Average glucose improved overall, but body size did not, and the improvement sat in the prediabetes group. In healthy people with normal blood sugar, the authors found no real benefit (Review). Only 7 of the 23 studies used a coin flip, so the base is thin.
Two more reviews ran into the same gap. One found 32 studies in people without diabetes, and exactly one of them tracked what happened to people’s health (Review). Another found just 7 studies of CGM-guided lifestyle change, all of them reporting glucose numbers rather than disease (Review).
Are the spikes themselves dangerous? A review of glucose swings in people without diabetes pooled 71 studies, most of them single snapshots (Review). Swings may track artery plaque and heart events, but that signal came from people who already had heart disease. Swings were not clearly linked to insulin sensitivity, fatty liver, body fat, blood fats or blood pressure. The same authors still think swings may matter here, and they want better studies (Review).
Studies that follow people forwards are rare. In one, 497 adults without diabetes wore a sensor for six days, then were tracked for about six years (Study). Twenty-five of them developed type 2 diabetes, and the size of their glucose swings flagged who reasonably well. The authors say no earlier study had tested this in a group like theirs. Hold it loosely: 25 cases is few, and the cutoff came from the same group it was tested on.
Meanwhile, crossing the famous 140 mg/dL line is ordinary. In a large community study, 560 adults with normal blood sugar spent about 3 hours a day above it, and 15 minutes above 180 (Study). A younger, healthier group of 153 people stayed between 70 and 140 mg/dL for 96% of the day (Study). An app flagging your post-lunch rise is not reporting a discovery.
One paper on “glucotypes” comes up a lot here. It found severe glucose swings in a quarter of people with normal standard tests (Study). That quarter was about 9 people out of 38. The whole study had 57 participants and no health follow-up. It describes patterns, not harm.
When the Sensor Gets It Wrong
Accuracy claims come mostly from people with diabetes, whose glucose runs higher. Down in the normal range, sensors do worse.
A 2025 trial tested an Abbott Libre 2 against finger-prick sampling in the same 15 healthy adults (Trial). The sensor read about 16 mg/dL too high, both fasting and after meals. It also claimed people spent roughly four times as long above 140 as they really did (Trial). Correct for the offset and it still doubled the figure.
That bias changes verdicts on food. The glycemic index ranks how much a food raises blood sugar. Judged by blood samples, whole fruit, blended fruit and a shop-bought smoothie all scored low. Judged by the sensor, all three came out medium (Trial). The same study found that blending fruit did not raise the response at all, which quietly kills a popular claim. Its senior author warned that sensors could push healthy people into needless food restrictions. Again, 15 people and one device, so hold it loosely.
In PREDICT 1, 394 healthy adults each wore two sensors side by side (Study). Two sensors of the same brand agreed almost perfectly. But in the 34 people who wore a Dexcom next to an Abbott, agreement was much weaker. About 1 meal in 5 flipped between the best and worst group, depending on which device you believed (Study). Ranking your own meals held up, and those authors read that as good news for personal food advice. The absolute numbers did not.
Smaller work points the same way. Against lab blood samples in 10 older adults without diabetes, a sensor was off by about 14% on average (Study). A finger-prick meter was off by about 8%. The sensor also under-read rises after meals, and it reported lows that were not real.
One more trap is the accuracy percentage printed on the box. A 2024 review of that number, written by two scientists at a sensor maker, found it depends heavily on who was studied (Review). No clinical study shows the number can separate a safe sensor from an unsafe one. So do not pick a device, or a personal threshold, off a decimal point.
What It Can Honestly Show You
A sensor earns its keep by comparing you against you. Ranking your own meals is the one job the hardware does reliably (Study). Pick one question, run it twice, and watch what happens.
Which of your usual breakfasts moves you most? Does a short walk after eating change the rest of your afternoon? We covered what walking after eating does to blood sugar separately, and it is the easiest thing to test. Does a late drink, or a bad night’s sleep, change tomorrow morning’s baseline?
Each of those needs a control: the same meal twice, on different days, at the same time. A single reading proves nothing. Duplicate meals a week apart agreed only loosely, even in the lab (Trial).
Two weeks of this may teach you more about your body than a year of general advice. It will not tell you whether you are healthy.
The Costs Nobody Mentions
A CGM is not a disease screen, and the paperwork says so (Source).
There is a measurement reason too. In 972 adults, sensor averages tracked the standard three-month blood test closely in people with type 2 diabetes (Study). In people with normal blood sugar, the two barely related. A fasting glucose or HbA1c from your doctor answers “am I at risk” directly and cheaply. It also comes with a reference range built for it.
Then there is the mood cost. Researchers surveyed 56 adults who had worn a CGM in the past year, some with diabetes and some without (Study). More than two thirds reported fear of developing type 2 diabetes when they saw a high reading. Distress ran higher in younger users and in users with obesity. People with more eating-disorder symptoms were most troubled by wearing the sensor itself (Study). In fairness, 89 in every 100 also reported eating better or moving more. It is one small survey, so treat it as a signal.
Harm here is under-measured rather than ruled out. A review of CGM use in people without diabetes called the effects on eating habits seriously under-researched. It called for commercial wellness claims to be labelled misleading (Review). The big 25-trial review cannot settle it either. Its outcomes were blood sugar, weight, diet and activity, and only 4 trials tracked what people ate (Review).
Money adds up too. Roughly $89 to $99 a month is about $1,000 a year, for data with no proven health payoff. Dexcom’s own store also notes that around one sensor in five may not last its full 15 days (Source).
Last is the pull of the score itself. A number on your phone invites you to push it down. Chasing a flat line is easy, and nobody has shown it is worth doing.
Frequently Asked Questions
Is a continuous glucose monitor worth it if I don’t have diabetes?
As a curiosity project, it can be. As a health investment, the evidence is not there yet. One review of 32 studies in people without diabetes found only one that looked at health outcomes (Review). A newer review found no real benefit in healthy people with normal blood sugar (Review).
Are glucose spikes bad if my blood sugar is normal?
Nobody knows yet, and going above 140 mg/dL after a meal is normal. In a large community study, adults with normal blood sugar spent about 3 hours a day above that line (Study). Glucose swings are linked to some risk markers, but almost entirely in snapshot studies. The heart signal came from people who already had heart disease (Review).
How accurate are over-the-counter CGMs?
Good enough to rank your own meals, not good enough to trust a single number. In 15 healthy adults, one popular sensor read about 16 mg/dL high and overstated time above 140 by roughly four times (Trial). The accuracy figure quoted on the box depends on who was studied, so brands cannot be compared on it (Review).
Do I need a prescription for a CGM?
Not in the US since 2024. Dexcom’s Stelo was cleared that March as the first over-the-counter glucose biosensor, for adults 18 and over who do not use insulin (Source). Abbott’s Lingo and Libre Rio followed in June, on the same no-insulin terms (Source).
Can wearing a CGM cause anxiety about food?
It may, for some people. In a survey of 56 users, more than two thirds reported fear of type 2 diabetes when they saw high readings (Study). Distress was higher in people with more eating-disorder symptoms. If food already causes you stress, this is probably not your device.
Key Takeaways
- Personal responses really do differ. 800 people across 46,898 meals showed identical food moving different people very differently (Study).
- The health benefit is unproven. In people without diabetes, reviews keep finding glucose numbers and almost no health outcomes (Review).
- Sensors read high in healthy people. A trial in 15 healthy adults found the sensor overstated time above 140 mg/dL by roughly four times (Trial).
- Use it to compare you against you. Same-brand sensors rank your own meals consistently, while different brands disagree on the numbers (Study).
- It is not a screening test. In people with normal blood sugar, sensor averages barely track the standard three-month blood test (Study).
- Watch the worry and the cost. Two thirds of surveyed users feared diabetes at high readings (Study), and the habit runs about $89 to $99 a month.
An Experiment, Not a Health Tool
Buy one sensor, not a subscription. Write your question down before you stick it on your arm. Two weeks is plenty for two or three honest comparisons.
Then take it off. A CGM is a good instrument for curiosity. It is not a score to beat.
If what you want to know is whether you are heading for diabetes, a cheaper answer already exists. Ask your doctor for a fasting glucose or an HbA1c. Those tests have decades of outcome data behind them. The sensor does not.
The evidence here is still being built, and it is worth watching.
This article is for educational purposes and is not medical advice. Talk to a qualified clinician before changing your health regimen.
Bio-Hacking.Blog 
Leave a comment